SD

Sheshmani Dwivedi

Active Director Director DIN 08052398
DIN 08052398 First appointment Mar 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2018
Shareholding value •••• Premium profile

About Sheshmani Dwivedi

Data last updated:

Sheshmani Dwivedi is a Director at Apsolabs Private Limited (since 2018). The company operates in Pharma. Apsolabs Private Limited reported revenue of ₹49.3 Lakh (FY 2024).

DIN 08052398
Primary Designation Director
Industry Pharma
First Appointment 22 Mar 2018
Oldest Company Age 8 yrs
Largest company Apsolabs Private Limited · ₹49.3 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Apsolabs Private Limited U33127UP2018PTC102386
Director22 Mar 20182018₹49.3 Lakh (FY 2024)Active

Board colleagues of Sheshmani Dwivedi

NameDINCompanyDesignation
Indra Mani Dwivedi08052421Apsolabs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Apsolabs Private Limited
Premium access

Shareholding and investment profile for Sheshmani Dwivedi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sheshmani Dwivedi

Sheshmani Dwivedi currently holds 1 directorship: Apsolabs Private Limited (Director, since 22 Mar 2018, revenue ₹49.3 Lakh (FY 2024)).

Sheshmani Dwivedi was first appointed on 22 Mar 2018 as Director at Apsolabs Private Limited.

The current boards of Sheshmani Dwivedi's companies include Indra Mani Dwivedi (Apsolabs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available